Journal
EXPERT OPINION ON DRUG DISCOVERY
Volume 5, Issue 5, Pages 461-474Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17460441003720467
Keywords
arrestin; bioluminescence resonance energy transfer; Dimer Translocation Assay; DimerScreen (TM); drug development; Enzyme Complementation Assay
Categories
Funding
- BBSRC [BB/E006302/1] Funding Source: UKRI
- MRC [G0900050] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/E006302/1] Funding Source: Medline
- Medical Research Council [G0900050] Funding Source: Medline
Ask authors/readers for more resources
Areas covered in this review: This review gives an overview of new strategies that have been developed in an effort to incorporate the possibilities added by GPCR hetero-oligomerisation on the screening of compounds as drug candidates. What the reader will gain: The reader will gain a wider knowledge about how the current understanding of GPCR oligomeric structure and function has mandated that hetero-oligomeric receptors must be considered as novel targets in the identification of future lead compounds. Take home message: For the improvement of novel drug discovery, more structural and functional information on the process of receptor oligomerisation is needed, and the realisation that the function of GPCRs can be greatly influenced by other interacting receptors or proteins also demands consideration in the lead-compound developing process in order to achieve better therapeutic agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available